Biotech Food Drug

Published between:
Published Title Organization
Mar
12
2025
Federal Circuit Affirms ImmunoGen Patent Obviousness ArentFox Schiff LLP
Mar
12
2025
Compounded GLP-1 Drugs: Texas Judge Denies PI Motion and Request for Stay of FDA’s Declaration that Tirzepatide Shortage is Resolved; Plaintiff OFA Appeals Foley & Lardner LLP
Mar
12
2025
GLP-1 Receptor Agonists and Patent Strategy: Securing Patent Protection for New Use of Old Drugs Foley & Lardner LLP
Mar
12
2025
Georgia Legislature Considering Substantial Overhaul to Medical Marijuana, Hemp Laws Bradley Arant Boult Cummings LLP
Mar
11
2025
Reminder: FDA Does, In Fact, Review DOF Sheppard, Mullin, Richter & Hampton LLP
Mar
11
2025
Federal Circuit Affirms District Court’s Obviousness Judgment on ImmunoGen Patent Application Polsinelli PC
Mar
11
2025
Leveraging USPTO Delays To Maximize Patent Term Foley & Lardner LLP
Mar
11
2025
SuperValu Wins False Claims Act Case with a “No Harm, No Foul” Jury Verdict Sheppard, Mullin, Richter & Hampton LLP
Mar
11
2025
Federal Appeals Court Rules Against Doctor Seeking to Use Mushrooms to Aide Terminal Patients: How We Learned to Question the Rationale of the Controlled Substances Act Bradley Arant Boult Cummings LLP
Mar
11
2025
EU Advocate General Recommends Overturning Decision Annulling Harmonized Classification and Labeling of Titanium Dioxide Bergeson & Campbell, P.C.
Mar
10
2025
Healthcare Preview for the Week of: March 10, 2025 [Podcast] McDermott Will & Schulte LLP
Mar
10
2025
Appellate Court Paves Way for Launch of Alabama Medical Cannabis Program: Watch What Happens Now Bradley Arant Boult Cummings LLP
Mar
9
2025
FDA Issues FSVP-Related Warning Letters Keller and Heckman LLP
Mar
7
2025
EPA Will Extend Deadline for Reporting Health and Safety Data for 16 Chemicals Bergeson & Campbell, P.C.
Mar
6
2025
First Circuit Adopts But-For Causation Standard for Kickback-Premised False Claims Act Actions K&L Gates LLP
Mar
5
2025
HHS Reverses Its Longstanding Policy and Limits Public Participation in Rulemaking Epstein Becker & Green, P.C.
Mar
5
2025
First Circuit Joins Other Circuits in Adopting Stricter Causation Standard in FCA Cases Based on Anti-Kickback Statute Bradley Arant Boult Cummings LLP
Mar
5
2025
Federal Circuit Refuses to Rehear Case Involving Orange Book Listing of Device Patents Polsinelli PC
Mar
5
2025
This Week in 340B: February 25 – March 3, 2025 McDermott Will & Schulte LLP
Mar
5
2025
How Alcohol Exporters Can Use FDII and IC-DISC to Maximize Tax Savings McDermott Will & Schulte LLP
Mar
5
2025
New State Legislative Efforts to Regulate Color Additives in Food Keller and Heckman LLP
Mar
5
2025
Meat Industry Pushes Back on Cultivated Meat Bans Keller and Heckman LLP
Mar
5
2025
Raw Milk: State Legislative Updates and Challenges Keller and Heckman LLP
Mar
5
2025
Cultivated Meat: Legislative Challenges from Georgia and South Dakota Keller and Heckman LLP
Mar
4
2025
Attention North Carolina Retailers: Time to Renew Your ABC Permits! Ward and Smith, P.A.
Mar
4
2025
Pest Practices: EPA Uses FIFRA EPA to Adopt Additional Operational and Workplace Controls on Ethylene Oxide K&L Gates LLP
Mar
4
2025
No Funny Business: The Supreme Court Should Get Sirois Bradley Arant Boult Cummings LLP
Mar
3
2025
Alabama Legislature Weighs Substantial Cannabis Reforms: Let’s All Take a Deep Breath Bradley Arant Boult Cummings LLP
Mar
2
2025
Connecticut Bill Addresses “Shrinkflation” Keller and Heckman LLP
Feb
28
2025
APHIS Will Begin Accepting Petitions for Nonregulated Status on March 3, 2025 Bergeson & Campbell, P.C.
Feb
28
2025
McDermott+ Check-Up: February 28, 2025 McDermott Will & Schulte LLP
Feb
27
2025
Florida Appellate Court Rules Hookah Products are Taxable OTP Jones Walker LLP
Feb
27
2025
A Regulatory Haze of Uncertainty Continues as the Clock Ticks Toward Phase One of FDA’s LDT Final Rule Epstein Becker & Green, P.C.
Feb
27
2025
Florida Court Rules That the Florida Constitution Required a Public Employer to Accommodate Off-Duty Medical Marijuana Use Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Feb
27
2025
TSCA Developments — A Conversation with Richard E. Engler, Ph.D. [Podcast] Bergeson & Campbell, P.C.
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters